These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 8769221

  • 41. Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.
    Falkenstein K, Dunn S.
    Transplant Proc; 1998 Aug; 30(5):1964-6. PubMed ID: 9723354
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Neoral without intravenous cyclosporine in liver transplantation.
    Hemming AW, Greig PD, Cattral MS, Chung SW, Lilly LB, Aljumah AA, Levy GA.
    Transplant Proc; 1997 Aug; 29(1-2):543. PubMed ID: 9123121
    [No Abstract] [Full Text] [Related]

  • 44. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH.
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group.
    Hoyer PF.
    Pediatr Transplant; 1998 Feb; 2(1):35-9. PubMed ID: 10084758
    [Abstract] [Full Text] [Related]

  • 47. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
    Jain A.
    Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
    [No Abstract] [Full Text] [Related]

  • 48. The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation.
    Schultz KR, Nevill TJ, Toze CL, Corr T, Currie C, Strong DK, Keown PA.
    Transplant Proc; 1998 Aug; 30(5):1668-70. PubMed ID: 9723236
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Reduced acute rejection and side effects with neoral in liver transplantation.
    Tisone G, Vennarecci G, Pisani F, Baiocchi L, Mercadante E, Orlando G, Anselmo A, Casciani CU.
    Transplant Proc; 1998 Jun; 30(4):1430-1. PubMed ID: 9636579
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Consensus statements on the optimal use of cyclosporine in pediatric patients.
    Brodehl J.
    Transplant Proc; 1994 Oct; 26(5):2759-62. PubMed ID: 7940869
    [No Abstract] [Full Text] [Related]

  • 56. Clinical impact of Neoral in thoracic organ transplantation.
    Aziz T, el-Gamel A, Keevil B, Krysiak P, Campbell C, Rahman A, Deiraniya A, Yonan N.
    Transplant Proc; 1998 Aug; 30(5):1900-3. PubMed ID: 9723326
    [No Abstract] [Full Text] [Related]

  • 57. Sandimmune Neoral in paediatric liver transplant recipients with malabsorption of cyclosporin A.
    Atkison PR, Grant DR, Williams SE, Howard J, Wall WJ, Stiller CR.
    Transplant Proc; 1994 Oct; 26(5):2953-4. PubMed ID: 7940931
    [No Abstract] [Full Text] [Related]

  • 58. Conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients.
    Zylber-Katz E, Doron D, Granot E.
    Transplant Proc; 1999 Jun; 31(4):1915-7. PubMed ID: 10372000
    [No Abstract] [Full Text] [Related]

  • 59. Importance of cyclosporine pharmacokinetics to clinical outcomes after liver transplantation. Canadian Liver Transplant Study Group.
    Transplant Proc; 1998 Aug; 30(5):1826-7. PubMed ID: 9723297
    [No Abstract] [Full Text] [Related]

  • 60. Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients.
    Lagget M, Marzano A, Actis GC, Leone N, Ciancio A, Salizzoni M, Rizzetto M.
    Transplant Proc; 1998 Aug; 30(5):1863-4. PubMed ID: 9723312
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.